Determination of Specificity and Sensitivity in Detecting Myocardial Infarction Using the EDE CARDIO BIO-MAP Machine
NCT07926230, Not yet recruiting, Weill Cornell Medical College in Qatar
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Determination of Specificity and Sensitivity in Detecting Myocardial Infarction Using the EDE CARDIO BIO-MAP Machine | ClinicalTrials.gov |
| NCT number | NCT07926230 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 200 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Weill Cornell Medical College in Qatar | ClinicalTrials.gov |
| Conditions | Myocardial Infarction | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Sensitivity and specificity of the EDE CARDIO BIO-MAP scanner(in vivo) for detecting myocardial infarction | Baseline | Sensitivity (true positives / \[true positives + false negatives\]) and specificity (true negatives / \[true negatives + false positives\]) of the scanner in emergency room patients with suspected myocardial infarction, compared with standard hospital laboratory results (cardiac troponin, creatine kinase-myocardial band, myoglobin, B-type natriuretic peptide, N-terminal pro-B-type natriuretic peptide) and the final clinical diagnosis in the medical record. | ClinicalTrials.gov |
| Secondary | Sensitivity and specificity of the portable lab's immediate blood measurements (in vitro) | Baseline | Sensitivity and specificity of the portable lab's immediate blood measurements for myocardial infarction, compared with conventional hospital laboratory measurements, using a confusion matrix. | ClinicalTrials.gov |
| Secondary | Accuracy of the EDE scanner | Baseline | Accuracy = (true positives + true negatives) / all results; | ClinicalTrials.gov |
| Secondary | Misclassification rate of the EDE scanner | Baseline | Misclassification rate = (false positives + false negatives) / all results; | ClinicalTrials.gov |
| Secondary | Precision of the EDE scanner | Baseline | precision = true positives / (true positives + false positives) | ClinicalTrials.gov |
| Secondary | Accuracy of the portable lab | Baseline | Accuracy = (true positives + true negatives) / all results; | ClinicalTrials.gov |
| Secondary | Misclassification rate of the portable lab | Baseline | Misclassification rate = (false positives + false negatives) / all results; | ClinicalTrials.gov |
| Secondary | Precision of the portable lab | Baseline | precision = true positives / (true positives + false positives) | ClinicalTrials.gov |
| Secondary | Correlation Between EDE Scanner and Portable Laboratory Values for Cardiac Biomarkers | Baseline | Pearson or Spearman correlation coefficient between scanner and portable lab values for cardiac biomarkers : Troponin T, Troponin I, Myoglobin, B-type Natriuretic Peptide, NT-proBNP, and Creatine Kinase-MB. | ClinicalTrials.gov |
| Secondary | Predictive power of each cardiac biomarker for myocardial infarction | Baseline | Logistic regression, area under the receiver operating characteristic curve, and optimal diagnostic cutoffs for each cardiac biomarker: Troponin T, Troponin I, Myoglobin, B-type Natriuretic Peptide, NT-proBNP, and Creatine Kinase-MB. | ClinicalTrials.gov |
| Other | Change in cardiac biomarker levels between initial assessment and 4-6 hour follow-up | Baseline and 4-6 hours after initial assessment | Change in cardiac biomarker levels( Troponin T, Troponin I, Myoglobin, B-type Natriuretic Peptide, NT-proBNP, and Creatine Kinase-MB) between the initial assessment and the follow-up, in participants who have a second clinical blood draw. | ClinicalTrials.gov |
| Other | Diagnostic performance of the scanner by sex | Baseline | Subgroup analysis of scanner sensitivity and specificity by sex | ClinicalTrials.gov |
| Other | Diagnostic performance of the scanner by age group | Baseline | Subgroup analysis of scanner sensitivity and specificity by age group | ClinicalTrials.gov |
| Other | Diagnostic performance of the scanner by symptom profile | Baseline | Subgroup analysis of scanner sensitivity and specificity by symptom profile. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)